MTOR and autophagy in regulation of acute lung injury: A review and perspective

Microbes and Infection

Volumn 16, Issue 9, 2014, Pages 727-734

  Hu, Yue ^a   Liu, Juan ^a   Wu, Yin Fang ^a   Lou, Jian ^a   Mao, Yuan Yuan ^a   Shen, Hua Hao ^a,b   Chen, Zhi Hua ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b State Key Laboratory of Respiratory Diseases   (China)

Author keywords

Acute lung injury; Autophagy; MTOR

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ACUTE LUNG INJURY; AUTOPHAGY; CELL TYPE; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; MACROPHAGE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACUTE LUNG INJURY; ANIMALS; AUTOPHAGY; HUMANS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84908158678     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2014.07.005     Document Type: Short Survey

References (79)

1. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
2. Choi A.M., Ryter S.W., Levine B. Autophagy in human health and disease. N Engl J Med 2013, 368:651-662.
3. Ryter S.W., Nakahira K., Haspel J.A., Choi A.M. Autophagy in pulmonary diseases. Annu Rev Physiol 2012, 74:377-401.
4. Mizumura K., Cloonan S.M., Haspel J.A., Choi A.M. The emerging importance of autophagy in pulmonary diseases. Chest 2012, 142:1289-1299.
5. Patel A.S., Morse D., Choi A.M. Regulation and functional significance of autophagy in respiratory cell biology and disease. Am J Respir Cell Mol Biol 2013, 48:1-9.
6. Rubenfeld G.D., Caldwell E., Peabody E., Weaver J., Martin D.P., Neff M., et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353:1685-1693.
7. Jacinto E., Loewith R., Schmidt A., Lin S., Rüegg M.A., Hall A., et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004, 6:1122-1128.
8. Peterson T.R., Laplante M., Thoreen C.C., Sancak Y., Kang S.A., Kuehl W.M., et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 2009, 137:873-886.
9. Kaizuka T., Hara T., Oshiro N., Kikkawa U., Yonezawa K., Takehana K., et al. Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. J Biol Chem 2010, 285:20109-20116.
10. Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002, 110:177-189.
11. Sancak Y., Thoreen C.C., Peterson T.R., Lindquist R.A., Kang S.A., Spooner E., et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 2007, 25:903-915.
12. Sarbassov D.D., Ali S.M., Kim D.H., Guertin D.A., Latek R.R., Erdjument-Bromage H., et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004, 14:1296-1302.
13. Frias M.A., Thoreen C.C., Jaffe J.D., Schroder W., Sculley T., Carr S.A., et al. mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol 2006, 16:1865-1870.
14. Pearce L.R., Sommer E.M., Sakamoto K., Wullschleger S., Alessi D.R. Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney. Biochem J 2011, 436:169-179.
15. Hay N., Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004, 18:1926-1945.
16. Johnson S.C., Rabinovitch P.S., Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature 2013, 493:338-345.
17. Wullschleger S., Loewith R., Hall M.N. TOR signaling in growth and metabolism. Cell 2006, 124:471-484.
18. Lamming D.W., Ye L., Katajisto P., Goncalves M.D., Saitoh M., Stevens D.M., et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science 2012, 335:1638-1643.
19. Thedieck K., Polak P., Kim M.L., Molle K.D., Cohen A., Jenö P., et al. PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis. PLoS ONE 2007, 2:e1217.
20. Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A., Vasquez D.S., et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008, 30:214-226.
21. Meijer A.J., Codogno P. AMP-activated protein kinase and autophagy. Autophagy 2007, 3:238-240.
22. Kim J., Kundu M., Viollet B., Guan K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of ULK1. Nat Cell Biol 2011, 13:132-141.
23. Chan E.Y., Kir S., Tooze S.A. siRNA screening of the kinome identifies ULK1 as a multidomain modulator of autophagy. J Biol Chem 2007, 282:25464-25474.
24. Jung C.H., Jun C.B., Ro S.H., Kim Y.M., Otto N.M., Cao J. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009, 20:1992-2003.
25. Ganley I.G., Lam du H., Wang J., Ding X., Chen S., Jiang X. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J Biol Chem 2009, 284:12297-12305.
26. Hosokawa N., Sasaki T., Iemura S., Natsume T., Hara T., Mizushima N. Atg101, a novel mammalian autophagy protein interacting with Atg13. Autophagy 2009, 5:973-979.
27. Yu L., McPhee C.K., Zheng L., Mardones G.A., Rong Y., Peng J., et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010, 465:942-946.
28. Matthay M.A., Ware L.B., Zimmerman G.A. The acute respiratory distress syndrome. J Clin Invest 2012, 122:2731-2740.
29. Matthay M.A., Zemans R.L. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol 2011, 6:147-163.
30. Johnson E.R., Matthay M.A. Acute lung injury: epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm Drug Deliv 2010, 23:243-252.
31. Xu F., Hu Y., Zhou J., Wang X. Mesenchymal stem cells in acute lung injury: are they ready for translational medicine?. J Cell Mol Med 2013, 17:927-935.
32. Crimi E., Slutsky A.S. Inflammation and the acute respiratory distress syndrome. Best Pract Res Clin Anaesthesiol 2004, 18:477-492.
33. Ware L.B., Eisner M.D., Thompson B.T., Parsons P.E., Matthay M.A. Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. Am J Respir Crit Care Med 2004, 170:766-772.
34. Flori H.R., Ware L.B., Milet M., Matthay M.A. Early elevation of plasma von Willebrand factor antigen in pediatric acute lung injury is associated with an increased risk of death and prolonged mechanical ventilation. Pediatr Crit Care Med 2007, 8:96-101.
35. Ware L.B., Conner E.R., Matthay M.A. von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit Care Med 2001, 29:2325-2331.
36. Flori H.R., Ware L.B., Milet M., Matthay M.A. Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation. Pediatr Crit Care Med 2003, 4:315-321.
37. Calfee C.S., Eisner M.D., Parsons P.E., Thompson B.T., Conner E.R., Matthay M.A., et al. Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury. Intensive Care Med 2009, 35:248-257.
38. Eisner M.D., Parsons P., Matthay M.A., Ware L., Greene K., et al. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003, 58:983-988.
39. Calfee C.S., Ware L.B., Eisner M.D., Parsons P.E., Thompson B.T., Wickersham N., et al. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008, 63:1083-1089.
40. Ware L.B., Matthay M.A., Parsons P.E., Thompson B.T., Januzzi J.L., Eisner M.D., et al. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007, 35:1821-1828.
41. Meduri G.U., Kohler G., Headley S., Tolley E., Stentz F., Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts poor outcome. Chest 1995, 108:1303-1314.
42. Parsons P.E., Eisner M.D., Thompson B.T., Matthay M.A., Ancukiewicz M., Bernard G.R., et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005, 33:1-6.
43. Miskolci V., Rollins J., Vu H.Y., Ghosh C.C., Davidson D., Vancurova I. NFkappaB is persistently activated in continuously stimulated human neutrophils. Mol Med 2007, 13:134-142.
44. Yang K.Y., Arcaroli J.J., Abraham E. Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am J Respir Crit Care Med 2003, 167:1567-1574.
45. Perl M., Lomas-Neira J., Chung C.S., Ayala A. Epithelial cell apoptosis and neutrophil recruitment in acute lung injury-a unifying hypothesis? what we have learned from small interfering RNAs. Mol Med 2008, 14:465-475.
46. Zemans R.L., Colgan S.P., Downey G.P. Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol 2009, 40:519-535.
47. Downey G.P., Dong Q., Kruger J., Dedhar S., Cherapanov V. Regulation of neutrophil activation in acute lung injury. Chest 1999, 116:46S-54S.
48. Perl M., Lomas-Neira J., Venet F., Chung C.S., Ayala A. Pathogenesis of indirect (secondary) acute lung injury. Expert Rev Respir Med 2011, 5:115-126.
49. Herold S., Mayer K., Lohmeyer J. Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Front Immunol 2011, 2:65.
50. Green D.R., Levine B. To be or not to be? How selective autophagy and cell death govern cell fate. Cell 2014, 157:65-75.
51. Li C., Liu H., Sun Y., Wang H., Guo F., Rao S., et al. PAMAM nanoparticles promote acute lung injury by inducing autophagic cell death through the Akt-TSC2-mTOR signaling pathway. J Mol Cell Biol 2009, 1:37-45.
52. Ma J., Sun Q., Mi R., Zhang H. Avian influenza A virus H5N1 causes autophagy-mediated cell death through suppression of mTOR signaling. J Genet Genomics 2011, 38:533-537.
53. Sun Y., Li C., Shu Y., Ju X., Zou Z., Wang H., et al. Inhibition of autophagy ameliorates acute lung injury caused by avian influenza A H5N1 infection. Sci Signal 2012, 5:ra16.
54. Pan H., Zhang Y., Luo Z., Li P., Liu L., Wang C., et al. Autophagy mediates avian influenza H5N1 pseudotyped particle-induced lung inflammation through NF-kappaB and p38 MAPK signaling pathways. Am J Physiol Lung Cell Mol Physiol 2014, 306:183-195.
55. Tanaka A., Jin Y., Lee S.J., Zhang M., Kim H.P., Stolz D.B., et al. Hyperoxia-induced LC3B interacts with the Fas apoptotic pathway in epithelial cell death. Am J Respir Cell Mol Biol 2012, 46:507-514.
56. Lee S.J., Ryter S.W., Xu J.F., Nakahira K., Kim H.P., Choi A.M., et al. Carbon monoxide activates autophagy via mitochondrial reactive oxygen species formation. Am J Respir Cell Mol Biol 2011, 45:867-873.
57. Chen Z.H., Lam H.C., Jin Y., Kim H.P., Cao J., Lee S.J., et al. Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-induced emphysema. Proc Natl Acad Sci U. S. a 2010, 107:18880-18885.
58. Lamb C.A., Dooley H.C., Tooze S.A. Endocytosis and autophagy: Shared machinery for degradation. Bioessays 2013, 35:34-45.
59. Barth J.M., Köhler K. How to Take autophagy and endocytosis up a Notch. Biomed Res Int 2014, 2014:960803.
60. Martinez J., Almendinger J., Oberst A., Ness R., Dillon C.P., Fitzgerald P., et al. Microtubule-associated protein 1 light chain 3 alpha (LC3)-associated phagocytosis is required for the efficient clearance of dead cells. Proc Natl Acad Sci U S A 2011, 108:17396-17401.
61. Stevens T. Functional and molecular heterogeneity of pulmonary endothelial cells. Proc Am Thorac Soc 2011, 8:453-457.
62. Lee S.J., Smith A., Guo L., Alastalo T.P., Li M., Sawada H., et al. Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension. Am J Respir Crit Care Med 2011, 183:649-658.
63. Marzetti E., Csiszar A., Dutta D., Balagopal G., Calvani R., Leeuwenburgh C. Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics. Am J Physiol Heart Circ Physiol 2013, 305:H459-H476.
64. Chong Z.Z., Shang Y.C., Maiese K. Cardiovascular disease and mTOR signaling. Trends Cardiovasc Med 2011, 21:151-155.
65. Nakahira K., Haspel J.A., Rathinam V.A., Lee S.J., Dolinay T., Lam H.C., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011, 12:222-230.
66. Harris J., Hartman M., Roche C., Zeng S.G., O'Shea A., Sharp F.A., et al. Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol Chem 2011, 286:9587-9597.
67. Peral de Castro C., Jones S.A., Ní Cheallaigh C., Hearnden C.A., Williams L., Winter J., et al. Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion. J Immunol 2012, 189:4144-4153.
68. Chuang S.Y., Yang C.H., Chou C.C., Chiang Y.P., Chuang T.H., Hsu L.C. TLR-induced PAI-2 expression suppresses IL-1β processing via increasing autophagy and NLRP3 degradation. Proc Natl Acad Sci U S A 2013, 110:16079-16084.
69. Lee S., Lee S.J., Coronata A.A., Fredenburgh L.E., Chung S.W., Perrella M.A., et al. Carbon monoxide confers protection in sepsis by enhancing beclin 1-dependent autophagy and phagocytosis. Antioxid Redox Signal 2014, 20:432-442.
70. Lorne E., Zhao X., Zmijewski J.W., Liu G., Park Y.J., Tsuruta Y., et al. Participation of mammalian target of rapamycin complex 1 in Toll-like receptor 2- and 4-induced neutrophil activation and acute lung injury. Am J Respir Cell Mol Biol 2009, 41:237-245.
71. Gomez-Cambronero J., Horn J., Paul C.C., Baumann M.A. Granulocyte-macrophage colony-stimulating factor is a chemoattractant cytokine for human neutrophils: involvement of the ribosomal p70 S6 kinase signaling pathway. J Immunol 2003, 171:6846-6855.
72. Wang L., Gui Y.S., Tian X.L., Cai B.Q., Wang D.T., Zhang D., et al. Inactivation of mammalian target of rapamycin (mTOR) by rapamycin in a murine model of lipopolysaccharide-induced acute lung injury. Chin Med J Engl 2011, 124:3112-3117.
73. Fielhaber J.A., Carroll S.F., Dydensborg A.B., Shourian M., Triantafillopoulos A., Harel S., et al. Inhibition of mammalian target of rapamycin augments lipopolysaccharide-induced lung injury and apoptosis. J Immunol 2012, 188:4535-4542.
74. Yen Y.T., Yang H.R., Lo H.C., Hsieh Y.C., Tsai S.C., Hong C.W., et al. Enhancing autophagy with activated protein C and rapamycin protects against sepsis-induced acute lung injury. Surgery 2013, 153:689-698.
75. Lo S., Yuan S.S., Hsu C., Cheng Y.J., Chang Y.F., Hsueh H.W., et al. Lc3 over-expression improves survival and attenuates lung injury through increasing autophagosomal clearance in septic mice. Ann Surg 2013, 257:352-363.
76. Liu Q.P., Zhou D.X., Lin P., Gao X.L., Pan L., Jin F.G. Participation of autophagy in acute lung injury induced by seawater. Exp Lung Res 2013, 39:441-452.
77. Hussain S.N., Mofarrahi M., Sigala I., Kim H.C., Vassilakopoulos T., Maltais F., et al. Mechanical ventilation-induced diaphragm disuse in humans triggers autophagy. Am J Respir Crit Care Med 2010, 182:1377-1386.
78. López-Alonso I., Aguirre A., González-López A., Fernández Á.F., Amado-Rodríguez L., Astudillo A., et al. Impairment of autophagy decreases ventilator-induced lung injury by blockade of the NF-κB pathway. Am J Physiol Lung Cell Mol Physiol 2013, 304:L844-L852.
79. Moy R.H., Gold B., Molleston J.M., Schad V., Yanger K., Salzano M.V., et al. Antiviral autophagy restrictsRift Valley fever virus infection and is conserved from flies to mammals. Immunity 2014, 40:51-65.